A breakthrough at the Research Institute of Mount Sinai Hospital may soon get many diabetics rid of the misery of taking insulin injections twice a day, for the researchers there have developed a once-a-week jab for type 2 diabetes patients.
Project leader Dr. Daniel Drucker has revealed that the new treatment called Exenatideis once a week, long-acting medications that imitates the action of GLP-1 (glucagon-like peptide), a naturally occurring hormone that is produced in the gut after eating, reports the Lancet.
During the study involving 300 patients, the researchers compared the results for patients self-injecting Exenatide once weekly against results from the conventional 14 injections a week.
They found that 75 per cent of patients receiving the once-weekly Exenatide treatment had their diabetes under control.
Insulin Delivery Devices
Insulin delivery devices have evolved drastically since their invention in 1922. They are all aimed to provide insulin to the patients with minimal discomfort.
Insulin delivery devices have evolved drastically since their invention in 1922. They are all aimed to provide insulin to the patients with minimal discomfort.
Source-ANI
LIN
What is Self-Monitoring of Blood Glucose
Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Diabetes.
Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Diabetes.
